Updates matching "National"

The U.S. House of Representatives and the U.S. Senate today introduced legislation aimed at eliminating health disparities. Sponsored by Rep. Raul Ruiz (D-CA) and Sen. Alex Padilla (D-CA), the Health Equity and Accountability Act of 2026 offers a comprehensive policy framework that will help address health inequities that intersect with race and ethnicity as well as geography, immigration status, age, disability, sex, gender, sexual orientation, gender identity and expression, language and socioeconomic status. The bill includes policy solutions that will help bolster cancer research and improve access to cancer prevention, early detection and care.

A coalition of public health organizations, pediatricians and parents today filed a federal lawsuit challenging the Food and Drug Administration’s new enforcement policy that allows e-cigarette and nicotine pouch products to be marketed and sold without the scientific review and marketing authorization required by federal law.

Nearly 200 patient advocacy, public health and health care professional organizations sent a letter to the Senate declaring their strong support for the Clinical Trial Modernization Act (S. 4440/H.R. 3521). The bipartisan, bicameral legislation would help remove cost and geographic barriers that keep patients from enrolling and participating in clinical trials. The bill was introduced in the U.S. Senate by Sens. Tim Scott (R-SC) and Mark Warner (D-VA) in April 2026 and in the U.S. House of Representatives in May 2025 by Reps. Raul Ruiz (D-CA) and August Pfluger (R-TX).

Today, the American Cancer Society and the American Cancer Society Cancer Action Network submitted a comment letter to the Office of Management and Budget strongly opposing a proposed rule that would change the federal government’s grantmaking framework.

WASHINGTON, D.C. – The following is a statement from Lisa Lacasse, president of the American Cancer Society Cancer Action Network: “The FDA’s job is to protect public health, not expand the profit margins of Big Tobacco. Authorizing new modified risk claims for 20 Zyn nicotine products – including flavored

WASHINGTON, D.C. – Yesterday, the U.S. Department of Health and Human Services (HHS) announced a coordinated effort across multiple agencies within the department to accelerate development of clinical research and remove barriers to clinical trial participation. As part of this initiative, the HHS Office of Inspector General (OIG)

WASHINGTON, D.C. – Today, the American Cancer Society Cancer Action Network (ACS CAN) submitted comments in a letter to the Department of Health and Human Services (HHS) and Centers for Medicare and Medicaid Services (CMS) applauding provisions of the 2026 Interoperability Standards and Prior Authorization for Drugs

Today, the House Committee on Appropriations considered and approved its draft FY27 appropriations bill and accompanying House Report that includes increases for the National Institutes of Health (NIH), the National Cancer Institute (NCI), and the Center for Disease Control and Prevention’s (CDC) Division of Cancer Prevention and Control (DCPC).

In late May, the Office of Management and Budget (OMB) released a proposed rule that would fundamentally change how federal grants and contracts would be awarded and managed, opening the door for interference and jeopardizing federal research investments. These changes would affect work funded by the National Institutes